Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

TOWARD A BIOCHEMICAL CLASSIFICATION OF DEPRESSIVE-DISORDERS .1. DIFFERENCES IN URINARY-EXCRETION OF MHPG AND OTHER CATECHOLAMINE METABOLITES IN CLINICALLY DEFINED SUBTYPES OF DEPRESSIONS ARCHIVES OF GENERAL PSYCHIATRY Schildkraut, J. J., Cole, J. O., ROHDE, W. A., LaBrie, R. A., Schatzberg, A. F., Gudeman, J. E., Orsulak, P. J. 1978; 35 (12): 1427-1433

Abstract

The urinary excretion of 3-methoxy-4-hydroxyphenylglycol (MHPG) and other catecholamine metabolites was measured in a series of 63 patients with various clinically defined subtypes of depressive disorders. MHPG excretion was significantly lower in patients with bipolar manic-depressive depressions and schizo-affective depressions than in patients with unipolar nonendogenous depressions. Patients with schizophrenia-related depressions also excreted reduced levels of MHPG when compared with patients with unipolar nonendogenous depressions. Moreover, levels of urinary epinephrine and metanephrine were significantly lower in patients with schizophrenia-related depressions. These data, coupled with our recent finding that patients with schizophrenia-related depressions had significantly higher levels of platelet monoamine oxidase activity than control subjects of patients with unipolar endogenous depressions, suggest that we can discriminate three biochemically discrete subgroups of depressive disorders corresponding to the following clinically defined subtypes: (1) the bipolar manic-depressive depressions plus the schizo-affective depressions; (2) the unipolar nonendogenous depressions; and (3) the schizophrenia-related depressions.

View details for Web of Science ID A1978GB74600003

View details for PubMedID 727878